Spontaneous Intracerebral Hemorrhage: Management

Overview

Journal J Stroke

Date 2017 Feb 9

PMID 28178413

Citations 42

Authors

Jun Yup Kim

Hee-Joon Bae

Affiliations

Soon will be listed here.

Abstract

Spontaneous non-traumatic intracerebral hemorrhage (ICH) remains a significant cause of mortality and morbidity throughout the world. To improve the devastating course of ICH, various clinical trials for medical and surgical interventions have been conducted in the last 10 years. Recent large-scale clinical trials have reported that early intensive blood pressure reduction can be a safe and feasible strategy for ICH, and have suggested a safe target range for systolic blood pressure. While new medical therapies associated with warfarin and non-vitamin K antagonist oral anticoagulants have been developed to treat ICH, recent trials have not been able to demonstrate the overall beneficial effects of surgical intervention on mortality and functional outcomes. However, some patients with ICH may benefit from surgical management in specific clinical contexts and/or at specific times. Furthermore, clinical trials for minimally invasive surgical evacuation methods are ongoing and may provide positive evidence. Upon understanding the current guidelines for the management of ICH, clinicians can administer appropriate treatment and attempt to improve the clinical outcome of ICH. The purpose of this review is to help in the decision-making of the medical and surgical management of ICH.

Citing Articles

Tungsten-based polyoxometalate nanoclusters as ferroptosis inhibitors modulating S100A8/A9-mediated iron metabolism pathway for managing intracerebral haemorrhage.

Yang Y, Lv M, Liu R, Yu P, Shen Z, Bai D J Nanobiotechnology. 2025; 23(1):122.

PMID: 39972331 PMC: 11837349. DOI: 10.1186/s12951-025-03149-9.

Predictors of In-Hospital Mortality in Spontaneous Intracerebral Hemorrhage in a Tertiary Hospital in Ghana: A Retrospective Analysis.

Limann B, Darko K, Osei E, Dwumfour-Poku N, Farid M, Nkansah S Neurosurg Pract. 2025; 5(4):e00120.

PMID: 39959546 PMC: 11809969. DOI: 10.1227/neuprac.0000000000000120.

Fto-dependent Vdac3 m6A Modification Regulates Neuronal Ferroptosis Induced by the Post-ICH Mass Effect and Transferrin.

Xu Z, Li H, Li X, Lu J, Cao C, Peng L Neurosci Bull. 2025; .

PMID: 39951182 DOI: 10.1007/s12264-025-01355-x.

An Update on Recent Drug Delivery Systems Targeting Brain Diseases via the Transnasal Pathway.

Zeng H, Lu H, Yang J, Hu P Pharm Res. 2024; 41(11):2121-2141.

PMID: 39477900 DOI: 10.1007/s11095-024-03790-3.

Serum IRAK3 may serve as a prognostic biomarker in acute supratentorial intracerebral hemorrhage: findings from a prospective observational cohort study.

Ma Y, Wang J, Tang C, Li W, Lv X, Zhu S Front Neurol. 2024; 15:1436997.

PMID: 39346771 PMC: 11427260. DOI: 10.3389/fneur.2024.1436997.

References

Cumming T, Thrift A, Collier J, Churilov L, Dewey H, Donnan G . Very early mobilization after stroke fast-tracks return to walking: further results from the phase II AVERT randomized controlled trial. Stroke. 2010; 42(1):153-8. DOI: 10.1161/STROKEAHA.110.594598. View

Heuts S, Bruce S, Zacharia B, Hickman Z, Kellner C, Sussman E . Decompressive hemicraniectomy without clot evacuation in dominant-sided intracerebral hemorrhage with ICP crisis. Neurosurg Focus. 2013; 34(5):E4. DOI: 10.3171/2013.2.FOCUS1326. View

Harenberg J, Erdle S, Marx S, Kramer R . Determination of rivaroxaban in human plasma samples. Semin Thromb Hemost. 2012; 38(2):178-84. DOI: 10.1055/s-0032-1301415. View

Kollmar R, Staykov D, Dorfler A, Schellinger P, Schwab S, Bardutzky J . Hypothermia reduces perihemorrhagic edema after intracerebral hemorrhage. Stroke. 2010; 41(8):1684-9. DOI: 10.1161/STROKEAHA.110.587758. View

Eckman M, Rosand J, Knudsen K, Singer D, Greenberg S . Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke. 2003; 34(7):1710-6. DOI: 10.1161/01.STR.0000078311.18928.16. View

Maramattom B, Weigand S, Reinalda M, Wijdicks E, Manno E . Pulmonary complications after intracerebral hemorrhage. Neurocrit Care. 2006; 5(2):115-9. DOI: 10.1385/NCC:5:2:115. View

De Herdt V, Dumont F, Henon H, Derambure P, Vonck K, Leys D . Early seizures in intracerebral hemorrhage: incidence, associated factors, and outcome. Neurology. 2011; 77(20):1794-800. DOI: 10.1212/WNL.0b013e31823648a6. View

Mendelow A, Gregson B, Rowan E, Murray G, Gholkar A, Mitchell P . Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet. 2013; 382(9890):397-408. PMC: 3906609. DOI: 10.1016/S0140-6736(13)60986-1. View

Lyden P, Shuaib A, Lees K, Davalos A, Davis S, Diener H . Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial. Stroke. 2007; 38(8):2262-9. DOI: 10.1161/STROKEAHA.106.472746. View

10.

Naff N, Williams M, Keyl P, Tuhrim S, Ross Bullock M, Mayer S . Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial. Stroke. 2011; 42(11):3009-16. PMC: 3356690. DOI: 10.1161/STROKEAHA.110.610949. View

11.

Poli D, Antonucci E, Dentali F, Erba N, Testa S, Tiraferri E . Recurrence of ICH after resumption of anticoagulation with VK antagonists: CHIRONE study. Neurology. 2014; 82(12):1020-6. DOI: 10.1212/WNL.0000000000000245. View

12.

Schreuder F, Sato S, Klijn C, Anderson C . Medical management of intracerebral haemorrhage. J Neurol Neurosurg Psychiatry. 2016; 88(1):76-84. DOI: 10.1136/jnnp-2016-314386. View

13.

Sun W, Pan W, Kranz P, Hailey C, Williamson R, Sun W . Predictors of late neurological deterioration after spontaneous intracerebral hemorrhage. Neurocrit Care. 2013; 19(3):299-305. PMC: 4100944. DOI: 10.1007/s12028-013-9894-2. View

14.

Fogelholm R, Murros K, Rissanen A, Avikainen S . Admission blood glucose and short term survival in primary intracerebral haemorrhage: a population based study. J Neurol Neurosurg Psychiatry. 2005; 76(3):349-53. PMC: 1739544. DOI: 10.1136/jnnp.2003.034819. View

15.

Beghi E, DAlessandro R, Beretta S, Consoli D, Crespi V, Delaj L . Incidence and predictors of acute symptomatic seizures after stroke. Neurology. 2011; 77(20):1785-93. DOI: 10.1212/WNL.0b013e3182364878. View

16.

Ji R, Shen H, Pan Y, Wang P, Liu G, Wang Y . A novel risk score to predict 1-year functional outcome after intracerebral hemorrhage and comparison with existing scores. Crit Care. 2013; 17(6):R275. PMC: 4056008. DOI: 10.1186/cc13130. View

17.

Sansing L, Messe S, Cucchiara B, Cohen S, Lyden P, Kasner S . Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH. Neurology. 2009; 72(16):1397-402. PMC: 2677505. DOI: 10.1212/01.wnl.0000342709.31341.88. View

18.

Anderson C, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C . Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013; 368(25):2355-65. DOI: 10.1056/NEJMoa1214609. View

19.

Sorimachi T, Fujii Y . Early neurological change in patients with spontaneous supratentorial intracerebral hemorrhage. J Clin Neurosci. 2010; 17(11):1367-71. DOI: 10.1016/j.jocn.2010.02.024. View

20.

Claassen J, Jette N, Chum F, Green R, Schmidt M, Choi H . Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology. 2007; 69(13):1356-65. DOI: 10.1212/01.wnl.0000281664.02615.6c. View